Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization

Journal of the National Cancer Institute

Volumn 93, Issue 12, 2001, Pages 921-929

  Lammering, Guido ^a,b   Hewit, Theodore H ^a   Hawkins, William T ^a   Contessa, Joseph N ^a   Reardon, Dean B ^c   Lin, Peck Sun ^a   Valerie, Kristoffer ^a   Dent, Paul ^a   Mikkelsen, Ross B ^a   Schmidt Ullrich, Rupert K ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL PROTECTION; COLONY FORMATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; FEMALE; GENE OVEREXPRESSION; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; INFUSION; IONIZING RADIATION; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIZATION; STATISTICAL ANALYSIS; TUMOR XENOGRAFT;

EID: 0035918858     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.12.921     Document Type: Article

References (53)

1. EGF receptor expression, regulation, and function in breast cancer
2. Genes for epidermal growth factor receptor, transforming growth factor and their expression in human gliomas in vivo
3. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas
4. Heregulins and the ErbB-2/3/4 receptors in gliomas
5. Radiation-induced autophosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells
6. The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells
7. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor
8. Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures
9. EGF receptor phosphorylation is affected by ionizing radiation
10. Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: A release from inhibition by epidermal growth factor
11. Signal transduction and cellular radiation responses
12. Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells
13. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells
14. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
15. Molecular mechanisms of radiation-induced accelerated repopulation
16. The hazard of accelerated tumor clonogen repopulation during radiotherapy
17. The mechanisms of acceleration of repopulation in squamous epithelia during daily irradiation
18. Repopulation in human tumors. A biological background for fractionation in radiotherapy
19. Prediction of repopulation rates and radiosensitivity in human tumours
20. Rapid repopulation in radiotherapy; a debate on mechanism. The phantom of tumor treatment-continually rapid proliferation unmasked
21. Anti-oncogenic activity of signaling-defective epidermal growth factor receptor mutants
22. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization
23. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells
24. Viral vectors for gene delivery
25. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir
26. Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion
27. Safranin O counterstaining enhances the counting of β-galactosidase-expressing cells
28. Distribution of macromolecular dyes in brain using positive pressure infusion: A model for direct controlled delivery of therapeutic agents
29. The molecular mechanism by which insulin stimulates glycogen synthesis in mammalian skeletal muscle
30. Plateau-phase cultures of mammalian cells: An in vitro model for human cancer
31. Mean inactivation dose: A useful concept for intercomparison of human cell survival curves
32. Cell survival curves
33. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumor
34. Adaptation of EGF receptor signal transduction to three-dimensional culture conditions: Changes in surface receptor expression and protein tyrosine phosphorylation
35. RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice
36. Rationally designed anti-HER2/neu peptide mimetic disables P185HER2/neu tyrosine kinases in vitro and in vivo
37. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis
38. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody
39. Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice
40. UVB-induced epidermal growth factor receptor phosphorylation is critical for downstream signaling and keratinocyte survival
41. Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors
42. The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities
43. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner
44. Recombinant humanized anti-HER2 antibody (Herceptin) enhances the anti-tumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts
45. Roles for basal and stimulated p21 (Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells
46. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma
47. Tyrosine kinase inhibition: An approach to drug development
48. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas
49. Heterodimerization and functional interaction between EGF receptor family members: A new signaling paradigm with implications for breast cancer research
50. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene
51. Frequent expression of a mutant growth factor receptor in multiple human tumors
52. Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts
53. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity